Search - tctmd.com

Displaying 581 - 600 of 643

Presentation TCT 2013

Is Urinary Neutrophil Gelatinase-Associated Lipocalin the “Renal Troponin” in Invasive Cardiology?

Presenter: Tilman Perrin, Eric Descombes, St?phanie Gobet, Jean-Luc Magnin, Magali Gachet, Ould Hemett, Daniel Hayoz, Val?rie Stolt, G?rard Baeriswyl, Jean-Christophe Stauffer, Jean-Jacques Goy, Mario Togni, St?phane Cook

January 31, 2013

Presentation TCT 2013

Histologic analysis of renal nerve injury following catheter-based renal denervation in obese, hypertensive canines

Presenter: Jeffrey Henegar, Yongxing Zhang, Rita DeRama, Cary Hata, John Hall

January 31, 2013

Presentation TCT 2013

Efficacy of renal denervation is positively impacted by longitudinal treatments

Presenter: Meital Mazor

January 31, 2013

Presentation TCT 2013

Clinical Efficacy and Cost per Quality-Adjusted –Life Years with Pararenal Endovascular Aortic Repair (PEVAR) for Para-renal AAA compared with Open Surgical Repair.

Presenter: Sherif Sultan, Niamh Hynes

January 31, 2013

Presentation TCT 2013

A Preclinical Comparative Histological Evaluation of the Renal Artery and Nerves in the Human Cadaver and Swine model

Presenter: Radhika Tunstall, Dawn Winsor-Hines, Martin Willard, Barbara Huibregtse

January 31, 2013

Presentation TCT 2013

A Pilot Study on Renal Sympathetic Denervation for Resistant Hypertension in the West of Ireland

Presenter: IMTIAZ KALYAR, James Gleeson, Sajjad Matiullah, Faisal Sharif

January 31, 2013

News Conference News TCT 2012

Mitral Valve-in-Valve Improves Outcomes in High-Risk Patients

October 29, 2012

Presentation TCT 2012

Case: A 62-Year-Old Diabetic Patient with ACS and Moderate Renal Failure

Presenter: Verghese Mathew

October 26, 2012

News Conference News TCT 2012

Friday, TCT 2012 Dailies

October 26, 2012

Presentation TCT 2012

Initiating a Renal Denervation Program

Presenter: George Dangas

October 25, 2012

News Conference News TCT 2012

POSEIDON: Sliding-Scale Hydration Successfully Prevents Contrast-Induced Nephropathy

October 25, 2012

News Conference News TCT 2012

More Data Needed on Renal Denervation

October 25, 2012

News Conference News TCT 2012

Experts Discuss Future of Renal Denervation

October 25, 2012

Presentation TCT 2012

Vincristine Local Delivery for Renal Artery Denervation

Presenter: Christodoulos Stefanadis

October 24, 2012

Presentation TCT 2012

The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry

Presenter: Felix Mahfoud

October 24, 2012

Presentation TCT 2012

Sympathetic Renal Denervation: 6 Month Results of the EnligHTN I Study (St. Jude Medical)

Presenter: Vasilios Papademetriou

October 24, 2012

Presentation TCT 2012

Extravascular Renal Denervation (Ablative Solutions)

Presenter: Tim Fischell

October 24, 2012

Presentation TCT 2012

What's Known and Not Known About Renal Denervation for Hypertension: Critical Appraisal of the Clinical Data

Presenter: Deepak Bhatt

October 24, 2012

Presentation TCT 2012

Translational Medicine and Renal Denervation: Preclinical Animal Models and Histoanatomy

Presenter: Renu Virmani

October 24, 2012

Presentation TCT 2012

Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology

Presenter: Michael Bohm

October 24, 2012

Advertisement

Is Urinary Neutrophil Gelatinase-Associated Lipocalin the “Renal Troponin” in Invasive Cardiology?

Histologic analysis of renal nerve injury following catheter-based renal denervation in obese, hypertensive canines

Efficacy of renal denervation is positively impacted by longitudinal treatments

Clinical Efficacy and Cost per Quality-Adjusted –Life Years with Pararenal Endovascular Aortic Repair (PEVAR) for Para-renal AAA compared with Open Surgical Repair.

A Preclinical Comparative Histological Evaluation of the Renal Artery and Nerves in the Human Cadaver and Swine model

A Pilot Study on Renal Sympathetic Denervation for Resistant Hypertension in the West of Ireland

Mitral Valve-in-Valve Improves Outcomes in High-Risk Patients

Case: A 62-Year-Old Diabetic Patient with ACS and Moderate Renal Failure

Friday, TCT 2012 Dailies

Initiating a Renal Denervation Program

POSEIDON: Sliding-Scale Hydration Successfully Prevents Contrast-Induced Nephropathy

More Data Needed on Renal Denervation

Experts Discuss Future of Renal Denervation

Vincristine Local Delivery for Renal Artery Denervation

The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry

Sympathetic Renal Denervation: 6 Month Results of the EnligHTN I Study (St. Jude Medical)

Extravascular Renal Denervation (Ablative Solutions)

What's Known and Not Known About Renal Denervation for Hypertension: Critical Appraisal of the Clinical Data

Translational Medicine and Renal Denervation: Preclinical Animal Models and Histoanatomy

Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content